ES2010524A6 - Procedimiento de obtencion de una composicion farmaceutica a base de antagonistas de calcio de utilidad en el tratamiento de hipertension y fallo cardiaco congestivo. - Google Patents

Procedimiento de obtencion de una composicion farmaceutica a base de antagonistas de calcio de utilidad en el tratamiento de hipertension y fallo cardiaco congestivo.

Info

Publication number
ES2010524A6
ES2010524A6 ES8703141A ES8703141A ES2010524A6 ES 2010524 A6 ES2010524 A6 ES 2010524A6 ES 8703141 A ES8703141 A ES 8703141A ES 8703141 A ES8703141 A ES 8703141A ES 2010524 A6 ES2010524 A6 ES 2010524A6
Authority
ES
Spain
Prior art keywords
compsns
use against
cardiac insufficiency
against hypertension
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8703141A
Other languages
English (en)
Inventor
Helene Siegl
Robert Paul Hof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2010524A6 publication Critical patent/ES2010524A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE UNA COMPOSICION FARMACEUTICA A BASE DE ANTAGONISTAS DE CALCIO DE UTILIDAD EN EL TRATAMIENTO DE HIPERTENSION Y FALLO CARDIACO CONGESTIVO. COMPRENDE MEZCLAR: A) UN ANTAGONISTA DE CALCIO DE FORMULA: EN DONDE A ES UN RESIDUO Y LOS OTROS RADICALES TIENEN LOS SIGNIFICADOS INDICADOS EN LA DESCRIPCION; Y B) EL INHIBIDOR DE ACE, ACIDO 7-(N-[1-(S)-ETOXICARBONIL-3-FENILPROPIL]-(S)-ALANIL-1,4-DITA-7-AZAESPIRO-[4,4] NONANO-8-(S)-CARBOXILICO, EN UNA RELACION A): B) DE 5:1 A 1:3 APROXIMADAMENTE.
ES8703141A 1986-11-03 1987-11-03 Procedimiento de obtencion de una composicion farmaceutica a base de antagonistas de calcio de utilidad en el tratamiento de hipertension y fallo cardiaco congestivo. Expired ES2010524A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2010524A6 true ES2010524A6 (es) 1989-11-16

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8703141A Expired ES2010524A6 (es) 1986-11-03 1987-11-03 Procedimiento de obtencion de una composicion farmaceutica a base de antagonistas de calcio de utilidad en el tratamiento de hipertension y fallo cardiaco congestivo.

Country Status (25)

Country Link
KR (1) KR960005145B1 (es)
AT (1) AT397343B (es)
AU (1) AU615883B2 (es)
BE (1) BE1002063A4 (es)
CA (1) CA1314222C (es)
CH (1) CH677189A5 (es)
DE (1) DE3736505A1 (es)
DK (1) DK574087A (es)
ES (1) ES2010524A6 (es)
FI (1) FI874823A (es)
FR (1) FR2605885B1 (es)
GR (1) GR871680B (es)
HK (1) HK138893A (es)
HU (1) HU199681B (es)
IE (1) IE60496B1 (es)
IL (1) IL84343A (es)
IT (1) IT1212037B (es)
LU (1) LU87034A1 (es)
MY (1) MY102124A (es)
NL (1) NL8702502A (es)
NO (1) NO874539L (es)
NZ (1) NZ222401A (es)
PH (1) PH23249A (es)
PT (1) PT86062B (es)
SE (1) SE8704272L (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2733911B1 (fr) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd Composition pharmaceutique pour maladies renales ou cardio-vasculaires

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
HUT47847A (en) 1989-04-28
GR871680B (en) 1988-05-02
FR2605885A1 (fr) 1988-05-06
NO874539L (no) 1988-05-04
FI874823A (fi) 1988-05-04
HU199681B (en) 1990-03-28
AU8057687A (en) 1988-05-05
PT86062B (pt) 1990-11-07
IL84343A0 (en) 1990-02-09
IL84343A (en) 1993-07-08
KR960005145B1 (ko) 1996-04-22
CA1314222C (en) 1993-03-09
CH677189A5 (es) 1991-04-30
DK574087A (da) 1988-05-04
NZ222401A (en) 1991-04-26
ATA286987A (de) 1993-08-15
IE872951L (en) 1988-05-03
PH23249A (en) 1989-06-16
SE8704272D0 (sv) 1987-11-02
MY102124A (en) 1992-03-31
PT86062A (en) 1987-12-01
AU615883B2 (en) 1991-10-17
LU87034A1 (fr) 1988-05-03
IE60496B1 (en) 1994-07-27
IT1212037B (it) 1989-11-08
SE8704272L (sv) 1988-05-04
FR2605885B1 (fr) 1993-09-10
NO874539D0 (no) 1987-11-02
DK574087D0 (da) 1987-11-02
FI874823A0 (fi) 1987-11-02
BE1002063A4 (fr) 1990-06-12
IT8748553A0 (it) 1987-10-30
HK138893A (en) 1993-12-24
DE3736505A1 (de) 1988-05-05
NL8702502A (nl) 1988-06-01
AT397343B (de) 1994-03-25
KR880006197A (ko) 1988-07-22

Similar Documents

Publication Publication Date Title
EP0200406A3 (en) Novel amino acid derivatives
MY102986A (en) Benzo (5,6) cycloheptapyridines, compositions and methods of use
EP0216539A3 (en) Novel amino acid derivatives
IL89868A0 (en) Pharmaceutical compositions for oral administration,based on diphosphonic acid derivatives
EP0244083A3 (en) Amino acid derivatives
EP0190891A3 (en) Novel amino acid derivatives
NO870049D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
ES8501411A1 (es) Un metodo para la preparacion de un derivado de aminoacido.
ES539799A0 (es) Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas.
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
ES2010524A6 (es) Procedimiento de obtencion de una composicion farmaceutica a base de antagonistas de calcio de utilidad en el tratamiento de hipertension y fallo cardiaco congestivo.
IE813100L (en) Naphthyridine derivatives
EP0215357A3 (en) Pharmaceutical preparation for the treatment of hypertension
ES8707729A1 (es) Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas.
EP0091525A3 (en) Phosphonoalkanoylamino acids
AU555803B2 (en) 6 amino-1,5-dihydro-4h-imidazo(4,5-c) pyridin-4-one salts
IT8619931A1 (it) Procedimento per la preparazione della 1-(N-metilamidino)-3-{2,6-dimetilfenil)urea e dei suoi sali farmaceuticamente accettabili
IT8822438A0 (it) Procedimento per la preparazione di ceftriaxone e i suoi sali farmaceuticamente accettabili.
IL81926A0 (en) Pharmaceutical compositions for the oral administration of active proteins
GB8823283D0 (en) Pharmaceutical composition for use against hypertension & congestive heart failure

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2007-11-03

PC1A Transfer granted